Temporal arteritis with erythrocyte sedimentation rate <50 mm/h: a clinical reminder

被引:9
作者
Cheema, Muhammad Raza [1 ]
Ismaeel, Hakawan M. [1 ]
机构
[1] Wirral Univ Teaching Hosp, Dept Geriatr, Wirral, Merseyside, England
关键词
temporal arteritis; giant cell arteritis; prednisolone; erythrocyte sedimentation rate; GIANT-CELL ARTERITIS; BIOPSY FINDINGS; FEVER;
D O I
10.2147/CIA.S40919
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Temporal arteritis, also known as giant cell arteritis (GCA), is a systemic vasculitis that predominantly involves the temporal arteries. It is a medical emergency and should be treated promptly as it can lead to permanent loss of vision. It is very commonly associated with a raised erythrocyte sedimentation rate (ESR), usually >50 mm/h, one of the essential criteria defined by the American College of Rheumatology classification of GCA. Here, we describe the case of a 73-year-old male presenting with a 2-day history of a sudden onset of a severe left-sided headache, which had the signs and symptoms consistent with GCA but he had an ESR of only 27 mm/h. The patient was urgently treated with prednisolone 60 mg per day, and his symptoms dramatically improved within 24 hours of therapy. Temporal artery biopsy results were consistent with an inflammatory response, and withdrawal of treatment led to a relapse of the symptoms. The patient was slowly tapered off the high steroid dose and is now currently managed on a low steroid dose. We should keep a high index of suspicion for GCA in patients presenting with clinical symptoms of GCA even though the ESR is <50 mm/h as stated in the criteria for GCA diagnosis.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 23 条
[1]   HOW DOES PREVIOUS CORTICOSTEROID TREATMENT AFFECT THE BIOPSY FINDINGS IN GIANT-CELL (TEMPORAL) ARTERITIS [J].
ACHKAR, AA ;
LIE, JT ;
HUNDER, GG ;
OFALLON, WM ;
GABRIEL, SE .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) :987-992
[2]   Audiovestibular manifestations in giant cell arteritis - A prospective study [J].
Amor-Dorado, JC ;
Llorca, J ;
Garcia-Porrua, C ;
Costa, C ;
Perez-Fernandez, N ;
Gonzalez-Gay, MA .
MEDICINE, 2003, 82 (01) :13-26
[3]  
[Anonymous], 2012, 27 EUR C EM MED, pP234
[4]  
Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO
[5]  
2-F
[6]   GIANT-CELL ARTERITIS (TEMPORAL ARTERITIS) PRESENTING AS FEVER OF UNDETERMINED ORIGIN [J].
CALAMIA, KT ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1981, 24 (11) :1414-1418
[7]   NEUROLOGIC COMPLICATIONS OF GIANT-CELL (TEMPORAL) ARTERITIS [J].
CASELLI, RJ ;
HUNDER, GG .
SEMINARS IN NEUROLOGY, 1994, 14 (04) :349-353
[8]   BSR and BHPR guidelines for the management of giant cell arteritis [J].
Dasgupta, Bhaskar ;
Borg, Frances A. ;
Hassan, Nada ;
Alexander, Leslie ;
Barraclough, Kevin ;
Bourke, Brian ;
Fulcher, Joan ;
Hollywood, Jane ;
Hutchings, Andrew ;
James, Pat ;
Kyle, Valerie ;
Nott, Jennifer ;
Power, Michael ;
Samanta, Ash .
RHEUMATOLOGY, 2010, 49 (08) :1594-1597
[9]  
Hassan Nada, 2011, BMJ, V342, pd3019, DOI 10.1136/bmj.d3019
[10]   Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature [J].
Hayreh, SS ;
Zimmerman, B ;
Kardon, RH .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 (04) :355-367